Acrivon Therapeutics, Inc. (ACRV)
NASDAQ:ACRV
US Market
Holding ACRV?
Track your performance easily

Acrivon Therapeutics, Inc. (ACRV) Financial Statements

159 Followers

Acrivon Therapeutics, Inc. Financial Overview

Acrivon Therapeutics, Inc.'s market cap is currently ―. The company's EPS TTM is $-2.767; its P/E ratio is -2.97; Acrivon Therapeutics, Inc. is scheduled to report earnings on March 26, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Jun 23Mar 23
Income Statement-
Total Revenue----$ 134.00K
Gross Profit----$ 134.00K
EBIT$ -18.80M$ -17.67M$ -21.05M$ -13.91M$ -14.39M
EBITDA$ -17.92M$ -17.44M$ -20.90M$ -12.58M$ -14.27M
Net Income Common Stockholders$ -18.80M$ -16.49M$ -19.25M$ -13.91M$ -12.76M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 180.54M$ 109.97M$ 127.46M$ 150.95M$ 120.21M
Total Assets$ 230.59M$ 120.52M$ 138.26M$ 160.05M$ 170.20M
Total Debt$ 4.22M$ 4.45M$ 4.64M$ 4.60M$ 4.79M
Net Debt$ -176.32M$ -105.53M$ -122.81M$ -146.35M$ -115.43M
Total Liabilities$ 14.53M$ 12.54M$ 17.07M$ 10.87M$ 9.73M
Stockholders Equity$ 216.06M$ 107.98M$ 121.19M$ 149.18M$ 160.47M
Cash Flow-
Free Cash Flow$ -14.04M$ -17.90M$ -13.52M$ -9.22M$ -11.38M
Operating Cash Flow$ -13.90M$ -17.08M$ -12.37M$ -9.11M$ -11.36M
Investing Cash Flow$ -88.04M$ 5.85M$ 20.54M$ 19.34M$ 9.33M
Financing Cash Flow$ 123.35M$ -172.00K$ -2.01M$ 379.00K-
Currency in USD

Acrivon Therapeutics, Inc. Earnings and Revenue History

Acrivon Therapeutics, Inc. Debt to Assets

Acrivon Therapeutics, Inc. Cash Flow

Acrivon Therapeutics, Inc. Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis